SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System

Surmodics (SRDX) recently announced the commercial launch of the Pounce XL Thrombectomy System, expanding its portfolio of vascular intervention solutions. Designed for efficient clot removal in larger vessels, the device enhances procedural effectiveness while offering a streamlined approach to treating thrombotic occlusions.As demand grows for advanced thrombectomy solutions, Surmodics’ latest innovation provides physicians with a reliable, catheter-based system for rapid clot extraction. By improving pro ...